Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487181 | 12548718 | 1 | I | 20160601 | 20160712 | 20160712 | PER | US-ABBVIE-16P-163-1642623-00 | ABBVIE | 0.00 | A | M | Y | 0.00000 | 20160712 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487181 | 12548718 | 1 | PS | VENCLEXTA | VENETOCLAX | 1 | Oral | UNKNOWN | 208573 | TABLET | |||||||||
| 125487181 | 12548718 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNKNOWN | 0 | TABLET | |||||||||
| 125487181 | 12548718 | 3 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125487181 | 12548718 | 1 | Chronic lymphocytic leukaemia |
| 125487181 | 12548718 | 2 | Tumour lysis syndrome |
| 125487181 | 12548718 | 3 | Prophylaxis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125487181 | 12548718 | Rash | |
| 125487181 | 12548718 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |